|
4-methyl-2-[4-(thiophen-2-yl)phenyl]morpholin-2-ol
|
M609344-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-methyl-2-[4-(thiophen-2-yl)phenyl]morpholin-2-ol
|
M609344-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-[4-(6-methoxynaphthalen-2-yl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine
|
M609343-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-[4-(6-methoxynaphthalen-2-yl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine
|
M609343-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-methyl-5-(5-methylpyridin-3-yl)-8-[(piperidin-4-yl)amino]-1,2-dihydro-1,7-naphthyridin-2-one
|
M609309-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-methyl-5-(5-methylpyridin-3-yl)-8-[(piperidin-4-yl)amino]-1,2-dihydro-1,7-naphthyridin-2-one
|
M609309-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one
|
M609299-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)-3-(pyrazin-2-ylmethylamino)pyrido[3,4-b]pyrazin-2-one
|
M609299-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(4-methoxybenzoyl)-5,5-dimethyl-1,3-oxazolidine-2,4-dione
|
M609264-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-(4-methoxybenzoyl)-5,5-dimethyl-1,3-oxazolidine-2,4-dione
|
M609264-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-methyl-7-(phenoxymethyl)-2H,3H,4H-pyrido[3,2-b][1,4]oxazine
|
M609237-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
4-methyl-7-(phenoxymethyl)-2H,3H,4H-pyrido[3,2-b][1,4]oxazine
|
M609237-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1-methylcyclopropyl) 4-[(1S)-1-fluoro-2-[[2-(2,3,6-trifluorophenyl)acetyl]amino]ethyl]piperidine-1-carboxylate
|
M609190-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(1-methylcyclopropyl) 4-[(1S)-1-fluoro-2-[[2-(2,3,6-trifluorophenyl)acetyl]amino]ethyl]piperidine-1-carboxylate
|
M609190-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-methoxy-4-{3-[4-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1H-indazol-6-yl}phenol
|
M609187-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-methoxy-4-{3-[4-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1H-indazol-6-yl}phenol
|
M609187-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
methyl (3R,5S,6E)-7-[3-bromo-4,5-bis(4-fluorophenyl)-2-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyhept-6-enoate
|
M609174-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
methyl (3R,5S,6E)-7-[3-bromo-4,5-bis(4-fluorophenyl)-2-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyhept-6-enoate
|
M609174-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-methyl-N-[2-({3-[2-(prop-2-enamido)acetamido]phenyl}amino)pyrimidin-5-yl]-5-[3-(trifluoromethyl)benzamido]benzamide
|
M609151-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
2-methyl-N-[2-({3-[2-(prop-2-enamido)acetamido]phenyl}amino)pyrimidin-5-yl]-5-[3-(trifluoromethyl)benzamido]benzamide
|
M609151-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-[(4-morpholin-4-ylbenzoyl)amino]-N-[(1S)-1-phenyl-2-pyrrolidin-1-ylethyl]-1H-thieno[5,4-d]pyrazole-5-carboxamide
|
M609148-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
3-[(4-morpholin-4-ylbenzoyl)amino]-N-[(1S)-1-phenyl-2-pyrrolidin-1-ylethyl]-1H-thieno[5,4-d]pyrazole-5-carboxamide
|
M609148-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-6-methoxy-N-[2-[(1-methylpiperidin-4-yl)methoxy]-4-(1H-pyrazol-4-yl)phenyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
|
M609131-5mg
|
Moligand™ |
N/A |
5mg
|
¥ 3999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |
|
(3R)-6-methoxy-N-[2-[(1-methylpiperidin-4-yl)methoxy]-4-(1H-pyrazol-4-yl)phenyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide
|
M609131-25mg
|
Moligand™ |
N/A |
25mg
|
¥ 5999.9
|
期货,请咨询 |
|
0 |
阿拉丁 |